CROI 2020 Program and Conference Information

Oral Sessions

86 AZITHROMYCIN FOR TREATMENT OF HIV-RELATED CHRONIC LUNG DISEASE IN AFRICAN CHILDREN Rashida A. Ferrand , Grace McHugh, Andrea M. Rehman, Hilda Mujuru, Mark Nicol, Sarah Rowland-Jones, Trond Flaegstad, Tore Gurtteberg, Victoria Simms, Elizabeth L. Corbett, Helen A. Weiss, Edith D. Majonga, Katharina Kranzer, Jon O. Odland, for the BREATHE Trial Group Oral Abstract O-08 Prevention 2020: Agents, Options, and Outcomes Ballroom A 10:00 AM - 12:00 PM Oral Abstract Moderators Lisa Hirschhorn , Northwestern University, Chicago, IL, USA Kenneth K. Mugwanya , University of Washington, Seattle , WA, USA 87 BIC/FTC/TAF POSTEXPOSURE PROPHYLAXIS PROTECTS MACAQUES AGAINST RECTAL SHIV INFECTION Elena Bekerman , Stephanie W. Cox, Scott McCallister, Tomas Cihlar, Christian Callebaut 88 ON-DEMAND HIV POSTEXPOSURE PROPHYLAXIS BY TAF/EVG VAGINAL INSERTS INMACAQUES Charles Dobard , M. Melissa Peet, Kenji Nishiura, Angela Holder, Onkar N. Singh, Timothy J. McCormick, James Mitchell, George Khalil, GerardoGarcia-Lerma, Vivek Agrahari, Pardeep Gupta, Sriramakamal Jonnalagadda, Walid Heneine, Gustavo Doncel, Meredith Clark 89 LB WEEKLY ORAL ISLATRAVIR PROVIDES EFFECTIVE PEP AGAINST IV CHALLENGEWITH SIVMAC251 Martin Markowitz, Agegnehu Gettie, Leslie St. Bernard, James Blanchard, Brooke Grasperge, Kerry Fillgrove, Lingling Xue, Neal Dube, Daria Hazuda, Jay Grobler 90 PHASE I PLACEBO-CONTROLED SAFETY, PK, AND PD STUDY OF MB66 ANTI-HIV AND ANTI-HSV FILM Susan Cu-Uvin , Thomas Moench, Joseph A. Politch, Karen T. Tashima, Jai G. Marathe, Kate M. Guthrie, Howard Cabral, Tara J. Nyhuis, Miles Brenna, Larry Zeitlin, Hans M. Spiegel, Kenneth H. Mayer, Kevin Whaley, Deborah Anderson 91 NEAR-PERFECT ACCURACY OF A REAL-TIME URINE TENOFOVIR TEST COMPARED TO LAB-BASED ELISA Matthew A. Spinelli , Warren Rodrigues, Guohong Wang, Michael Vincent, David Glidden, Randy Stalter, Patricia A. Defechereux, Madeline Deutsch, Robert M. Grant, Kenneth Ngure, Nelly R. Mugo, Jared Baeten, Monica Gandhi, for the Partners PrEP and IBrEATHe 92 LONGER-TERMSAFETY OF F/TAF AND F/TDF FOR HIV PrEP: DISCOVER TRIALWEEK-96 RESULTS Onyema Ogbuagu , Daniel Podzamczer, Laura C. Salazar, Keith Henry, David M. Asmuth, David Wohl, Richard Gilson, Yongwu Shao, Ramin Ebrahimi, Christoph Carter, Moupali Das, Scott McCallister, Jason M. Brunetta, Gitte Kronborg, Christoph D. Spinner 93 INITIATING PrEP DURING ACUTE HIV INFECTION:WHAT IS THE RISK FOR ARV DRUG RESISTANCE? Donn J. Colby , Chanjiraporn Pondet, Tippawan Pankam, Prapaipan Plodkratok, Rapee Trichaviroj, Carlo Sacdalan, Eugène Kroon, Siriwat Akapirat, Jintanat Ananworanich, Mark De Souza, Praphan Phanuphak, Sandhya Vasan, Nittaya Phanuphak, for the RV254/SEARCH010 Research Group 11:30 10:00 10:15 10:30 10:45 11:00 11:15 11:30

Oral Sessions • Tuesday

CROI 2020 47